Alpha Mark Advisors, LLC Mannkind Corp Transaction History

Alpha Mark Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 06, 2020	SELL	$1.56 - $2.08 $12,606 - $16,808	-8,081 Closed	0 $0
Q1 2020 Apr 24, 2020	BUY	$0.84 - $1.76 $1,344 - $2,816	1,600 Added 24.69%	8,081 $8,000
Q3 2019 Nov 01, 2019	BUY	$1.04 - $1.44 $2,080 - $2,880	2,000 Added 44.63%	6,481 $8,000
Q1 2019 May 09, 2019	BUY	$1.14 - $2.25 $5,108 - $10,082	4,481 New	4,481 $9,000

243

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.57B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Alpha Mark Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Mark Advisors, LLC with notifications on news.